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Background: The NF-κB and IRF transcription factor families are major players in inflammation and antiviral response
and act as two major effectors of the innate immune response (IIR). The regulatory mechanisms of activation of these
two pathways and their interactions during the IIR are only partially known.
Results: Our in silico findings report that there is cross-regulation between both pathways at the level of gene
transcription regulation, mediated by the presence of binding sites for both factors in promoters of genes essential
for these pathways. These findings agree with recent experimental data reporting crosstalk between pathways
activated by RIG-I and TLR3 receptors in response to pathogens.
Conclusions: We present an extended crosstalk diagram of the IRF - NF-κB pathways. We conclude that members
of the NF-κB family may directly impact regulation of IRF family, while IRF members impact regulation of NF-κB
family rather indirectly, via other transcription factors such as AP-1 and SP1.
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Identification of pathogen-associated molecules, such as
dsRNA and lipopolysaccharide (LPS), by host pattern
recognition receptors (PRRs) is a critical step in innate
immune response (IIR). Stimulation of TLRs (Toll-Like
Receptors) by a pathogen induces activation of signal
transduction cascades, which leads to translocation of
nuclear factor-κB (NF-κB) to the nucleus [1], activation
of interferon regulatory factors 3/7 (IRF3/7) and/or activa-
tor protein-1 (AP-1), which cooperate to induce transcrip-
tion of various cytokines such as alpha/beta interferon
(IFN-α/β) to counteract infection [2-4]. In this paper we
analyze crosstalk between the two major signaling path-
ways in the IIR system, namely the NF-κB and IRF path-
ways. The regulatory mechanisms of activation of these
two pathways and their interactions during the IIR are
only partially known. Recent work by the Brasier’s group
and others has shown that IRF3-dependent and NF-κB-
dependent pathways are interconnected at multiple steps,
with the final shared component being the IκB kinase-γ* Correspondence: marta.iwanaszko@polsl.pl
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article, unless otherwise stated.(IKKγ) subunit [5,6]. Single-cell imaging experiments have
provided information about cellular heterogeneity of these
interactions but exact molecular mechanisms are not clear
yet [7,8]. In the canonical model, IFN regulation, after
RNA virus infection, is conducted by IRF-3 and IRF-7. An
explanation was presented by Covert et al. [9] who pro-
posed that the activation of NF-κB by TRIF-dependent
pathway is a result of a secondary response to TNFα,
which is induced by IRF3 (this latter activated by the
TLR4/TRIF-mediated pathway in the first response to
LPS) and signals through the TNFα receptor (TNFR)/
RIP1 pathway to activate NF-κB. Knowledge about the
crosstalk between NF-κB and IRF pathways may be crucial
for determining the outcome of viral infection. Most IRF
family members are expressed only in specialized cell
types, but IRF-3 is widely expressed [10], stimulating syn-
thesis of IFNβ in infected cells. Because of this extensive
presence, IRF-3 function is widely targeted by viruses [11],
and thus its activity has to be aided by IRF-7 which takes
a major part in amplification of the antiviral response. Re-
search on NF-κB-deficient cells has shown that the initial
kinetics of the type I interferon (IFN) response depends
on concurrent NF-κB activation [12]. Experimental data
show that in the absence of NF-κB, the rapid IFNβ expres-
sion is blunted, reducing the propagation of anti-viraled Central. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this









IRF1 Human (var*) 1 0 37 13
Mouse (var) 0 0 23 8
Chimpanzee 1 0 37 13
Cattle 2 0 40 14
IRF2 Human 7 2 12 6
Mouse (var) 8 2 24 8
Chimpanzee 4 1 10 7
Cattle 8 2 21 7
IRF3 Human (var) 1 1 5 4
Mouse (var) 2 1 17 9
Chimpanzee 2 1 5 4
Cattle 2 1 12 5
NFKB1 Human 6 2 21 6
Mouse (var) 1 0 3 2
Chimpanzee 5 2 19 5
Cattle 5 0 2 2
NFKB2 Human (var) 0 0 24 8
Mouse (var) 0 0 24 8
Chimpanzee 0 0 25 8
Cattle 0 0 27 9
RELA Human 1 0 18 6
Mouse 2 1 14 6
Chimpanzee 1 0 6 2
Cattle 0 0 8 4
REL Human 1 0 28 5
Mouse 0 0 28 7
Chimpanzee 1 0 21 3
Cattle 7 0 4 1
Summary of the counts of TFBS corresponding to the members of IRF and
NF-κB families of transcription factors found in the promoters of presented
genes in four species: human, mouse chimpanzee and cattle. Motifs overlap;
numbers in bold correspond to promoters containing 2 or more IRF3 motifs.
Detailed results are presented in Additional file 1. *var – other variants of the
promoter exist.
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expression of the downstream IFN auto-amplification loop
through STAT1, IRF-1, −5, and −7 transcription factors.
Taking these findings into consideration it seems logical,
that activity of IIR depends on cooperation of both arms
of this system and indicate that NF-κB and IRF3 signaling
pathways are highly interconnected and that these inter-
connections influence the kinetics of the IIR [14].
In this paper we examine evidence for a direct cross-
talk of the NF-κB and IRF3 signaling pathways at the
lowest level, between main transcription factors and
genes coding for these transcription factors. Based on
experimental data we believe that cross-talk at this level
may strongly impact cross-regulation at higher levels.
We analyzed respective gene promoters’ sequences using
in silico methods for identification of transcription bind-
ing sites, mainly in the NF-κB- and IRF-coding genes.
We cross-reference these in silico results with publicly
available ChIP-seq data and additional support based on
the experimental results from our previous work [13]. Our
results extend the results obtained by Brasier’s group.
Results and discussion
Interaction between IRF3 and NF-κB Pathways
Using computational methods and cross-species com-
parisons among human, chimpanzee, mouse and cattle,
we analyzed promoters of genes encoding factors in-
volved in IRF and NF-κB pathways. In the first step of
analysis we were looking for hypothetical transcription
factor binding sites (TFBSs) across given promoter re-
gion and in the second step we verified if these TFBS
were conserved among species in the conserved do-
mains. Similar method of transcription factor binding
sites analysis was used in Iwanaszko et al. [15]. Pro-
moters of downstream genes, mainly coding for tran-
scription factors involved, contain one or more binding
sites for IRF and/or NF-κB; partial results are presented
in Table 1. Detailed results of analysis of binding to the
promoters of the transcription factor genes are pre-
sented in Additional file 1. Similar results have been ob-
served for other important genes regulated by NF-κB.
The promoter of IFN-β contains NF-κB binding sites
and two IFN-stimulated responsive elements (ISREs)
recognized by phosphorylated IRF3/7 (data not shown).
Previous studies showed that the activity of cooperating
regulatory proteins recruited to DNA binding transcrip-
tion factors play an important role in regulation of gene
expression [16-19]. It was already demonstrated [20] that
activation of the IP10 but not MCP-1 promoter, both of
which contain NF-κB binding sites differing in one and
two nucleotides, requires IRF3 as a co-activator follow-
ing LPS stimulation. This suggests that the binding site
sequence composition has an influence on the type of
cooperative proteins that are recruited to complex withthe NF-κB dimer. Formerly it was also shown that the
glucocorticoid receptors can selectively trans-repress the
transcription of a subset of genes (such as Scyb9), with
promoters which use IRF3 as an essential co-activator of
NF-κB binding upon LPS stimulation [21]. This indicates
that binding sites arrangement and possible co-activators/
co-repressors are critical for gene expression and thus this
knowledge grants a deeper insight into the IRF and NF-κB
cross-regulation. It is known that TFBS found using com-
putational methods may be non-functional, and therefore
we cross-referenced our results with publicly available
ChIP-seq data for IRF3, IRF1 and NF-κB.
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In the IRF3 gene, we can distinguish 3 variants of pro-
moters in the human and mouse genomes. In humans
two of these variants have a single binding site for IRF3
and IRF1, and at the same time have a higher number of
NF-κB TFBSs (4 for c-Rel, 1 for NF-κB). Two variants of
promoters are placed on the negative strand, adjacent to
the part covering 1st and 2nd intron and adjacent exons of
gene BCL2L12. In the human-chimpanzee comparison, one
IRF TFBS is conserved. There are no IRF binding sites con-
served in human-mouse or human –cattle comparisons.
In the IRF1 gene there are no conserved binding sites
for IRF but a good conservation of NF-κB binding sites
was detected. Interestingly, human IRF1 gene has the
highest count of TFBS for p50 and p65 subunit in the
dataset. Analysis of single promoter sequences shows
that the IRF1 gene has binding sites only for the IRF1
and none for the other IRF family members. This may
be an example of autoregulation feedback aided by other
transcription agents, such as SP1 and AP-1 or even by
members of the NF-κB family.
In IRF2 there is no conservation between human and
chimpanzee, but there is a good conservation of TFBS
for human-mouse and human-cow comparison (con-
served sites for IRF1, IRF2 and IRF3, as well as for the
NF-κB family members). Analyzing activity of the IRF
family members on their coding genes suggests that
regulation is connected with IRF1 activity, based on the
number and type of TFBS in promoter region of IRF
coding genes, while IRF2 does not take any direct part
in regulation of IRF genes. Another conclusion is that
regulation of the IRF genes appears to be more sensitive
to the direct NF-κB binding than to the IRFs binding,
yet unknown transcription factors could be involved.
This conclusion is based on the number of TFBS that
have been found in the promoters of genes from both
transcription factor families.
NF-κB Family
On the human NFKB1 gene promoter, we have found 2
TFBS for the IRF family members: one overlapping site
for IRF1/IRF3 and second overlapping binding site for
the IRF1/NF-κB family. In chimpanzee we have found 4
TFBS for IRF family members, two of them were over-
lapping IRF1/IRF3 binding sites. Only one IRF1/IRF3 site
is conserved between human and chimpanzee, there is no
conservation with cattle (4 sites for IRF1, no IRF3 and
IRF2) or mouse (1 site for IRF1, 1 for IRF3, no IRF2).
For the NFKB2 promoter, we did not find any IRF
family TFBSs in all species, apart from 1 weak binding
site for the IRF3 in 2 of 4 promoter variants in mouse,
overlapping stronger the NF-κB family binding sites.
For the RELA gene, a single IRF1 TFBS was found in
the human promoter, however there is no TFBS for IRF2or IRF3. No IRF binding sites were found in the cattle
RELA gene, but 1 TFBS was found in chimpanzee, and
two in the mouse RELA gene. None of those were evolu-
tionarily conserved.
There is one IRF1 TFBS in the REL gene, but high
number of TFBS for the NF-κB family members. High
number of IRF1 TFBS was found only in cattle promoter
(6), and none for IRF3.
In the NFKBIA (IκBα) promoter, we have found bind-
ing sites primarily for IRF1: 2 in humans, 2 in cattle, 3 in
mouse and one in chimpanzee. In human and mouse
one of IRF1 TFBS overlaps with weaker IRF3 binding
motif. NFKBIA gene promoter contains a high number
of NF-κB family binding sites, which are not adjacent to
the sparsely distributed IRF binding sites.
Analysis of the promoter region in the NFKBIE (IκBε)
gene showed similarly moderate counts of the IRF and
NF-κB TFBS, with strong overlapping IRF1/IRF2/IRF3
sites in human, chimpanzee and cattle. In the mouse gene
we have found only one binding site for IRF3. Only this
gene shows higher than usual count of IRF3 binding sites.
Analysis of 3’UTR Region
In previous research [22] IRF1 gene was grouped as one
of the NF-κB-dependent genes, and according to dynam-
ics of gene expression, as an “Early” gene. At the pro-
moter sequence level it can be clearly seen in our data,
based on the number of TFBS for NF-κB family. Taking
this into consideration we adopted approach presented
in Iwanaszko et al. [15] to analyze the 3’UTR regions of
the IRF coding genes, in order to look for possible se-
quence characteristics similar to those of the NF-κB
transcription factor coding genes. Analysis of the 3’UTR
regions of human IRF coding genes shows, that the IRF1
3’UTR is the longest one with more than 2000 bp and
contains one motif of the ARE class II, 4 motifs of the
ARE class I and 8 sequences categorized as the ARE
class III, with AT-content around 50%. This is consistent
with characteristics of the Early NF-κB-dependent genes.
IRF2 3’UTR region is in the 1000 bp range with 9 se-
quences categorized as ARE class III and only one ARE
I, with AT content around 60%.
The 3’UTR sequence for IRF3 is strikingly different
from other two, with only 89 bp length and 42.50% AT
content, and no ARE elements present. This may suggest
that the IRF3 transcript is very stable. Taking into con-
sideration the promoter and 3’UTR characteristics it is
possible that IRF2 and IRF3 are also highly responsive to
the NF-κB activity.
Possible cofactors
When we analyzed the promoters of the genes coding for
IRFs and the NF-κB subunits we observed presence of the
binding sites for the two other transcription factors, which
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pathways. One of these transcription factors is AP-1
(JUN), which is active in the TLR signaling pathways and
is needed for IFNβ activation [23], and the second one is
the SP1, which is reported to act with NF-κB2 subunit in
antiviral immune response [24].
Based on TFBS search it seems that AP-1 and SP1
may be regulated by each other. We did not find binding
sites for the IRF family members in the AP-1 promoter
region except for one IRF1 site. Expression of AP-1
seems to be co-regulated by the NF-κB family members,
having binding sites for REL (6 sites), RELA (4 sites) and
NFKB1 (4 sites). Regulation of the SP1 expression seems
to be independent of direct IRF binding, but may be
triggered by the NF-κB. We found 5 theoretical binding
sites for the Rel subunit, and one for NF-κB2, which is
confirmed to be functional [24]. SP1 was believed to
bind sites in GC-rich regions and act as universal activa-
tor of housekeeping genes [25], however reports impli-
cate, that SP1 is responsive to intracellular signals. In
our dataset GC-content fluctuates around 60%; only the
promoters of NFKB2 and NFKBIA genes have less than
55% of GC bases. It is interesting that the IRF genes
have rather high GC content in our ranking (with the
IRF1 having one of the highest: 64.7%), but do not have
the highest count of the SP1 binding sites. It seems that
the RELA and RELB genes may be the most the SP1-
responsive targets; details are presented in Table 2. To
analyze the specificity of presence of AP-1 and SP1 bind-
ing sites, we generated a set of 100 random 1 kb se-
quences, which were analyzed in the same way, as our
primary dataset. We compared the average count of
TFBSs belonging to AP-1 and SP1 in both datasets, and
summary results show that AP-1 seems to be less
dataset-specific than SP1 (AP-1DATA = 8.2, AP-1RAND
= 9.29; SP1DATA = 7.4, and SP1RAND = 2.4), and thus
we propose SP1 as a stronger candidate for a co-factor
in the NF-κB/ IRF3 crosstalk.Table 2 GC content and TFBS for cofactors in dataset
Gene name GC % AP-1 SP1
IRF1 64.70 5(5) 11(24)
IRF2 61.50 10(11) 11(25)
IRF3 58.90 5(5) 8(21)
NFKB1 55.50 10(11) 8(17)
NFKB2 51.90 6(7) 9(22)
REL 61.30 4(4) 17(41)
RELA 65.70 5(6) 11(18)
RELB 56.40 9(11) 13(34)
GC content and counts of SP1 and AP-1 binding sites in promoter region of
human genes encoding the analyzed transcription factors. Numbers in paren-
theses are the counts of overlapping motifs.Validation of in silico findings
In order to increase support for the computationally
found binding sites, we performed cross-species com-
parison and indicated promoter binding regions that
were conserved. Additionally we analyzed publicly avail-
able ChIP-seq data, to compare in silico binding sites
with experimental results. We analyzed NF-κB ChIP-seq
experiments in 10 cell lines, in one cell line for IRF1,
and in 3 cell lines for IRF3, all available under the EN-
CODE project [26]. Detailed data on cell lines are pre-
sented in Methods section. There is only one cell line,
GM12878 from blood tissue, in which activity of both
transcription factors, NF-κB and IRF3, was analyzed and
can be compared. In general, data for NF-κB are consist-
ent among all cell lines considered, and peaks and a
strong signal are present in the same regions as those
determined computationally, in almost all analyzed cell
lines. In case of IRF3 data, the agreement depends on
cell line. In particular in HepG cells nearly no binding
signal was found for our set of genes. In the promoter of
NFKB1 gene very strong and broad peak was found in
all cell lines, with the strongest peak centered near TSS
(transcription start site) which is consistent across all ex-
periments, and a few smaller peaks which are placed in
further parts of promoter region. In summary, the compu-
tationally found TFBS are located in the experimentally
confirmed binding region. Binding region in the proximity
of TSS is also conserved in the species analyzed. In the
case of IRF3 binding, we observe a weak binding signal be-
tween 450b and 1000b upstream from TSS, what is also
consistent with our in silico findings. In the dataset for
IRF1, a weak binding signal is present across the promoter
region and a stronger broad peak is overlapping with the
NF-κB binding region in the proximity of TSS. Our com-
putational data found IRF1 TFBS further upstream in the
promoter region, but none near TSS.
In the promoter of the NFKB2 gene again we see con-
sistent binding across all cell lines used for NF-κB binding
analysis. Shorter gene variants have 2 strong peaks in their
promoter region (intron of the longer NFKB2 variant),
these regions agree with location of computationally found
TFBS for NF-κB family. This binding region overlaps with
the strong peak for IRF1 binding, and in these variants we
found only one TFBS. In the longer variant our computa-
tional analysis shows no TFBS, and ChIP-seq data show
binding peak in the region of the first exon of NFKB2, but
nearly no signal in the promoter region. There is no bind-
ing signal for IRF3 in the promoter region of any variant
of this gene which is consistent with lack of computation-
ally found TFBS.
In the RELA gene promoter, a strong binding signal for
NF-κB is present in 9 out of 10 cell lines, 5 of which are
defined peaks and are mostly consistent with the binding
sites computationally located in the region further upstream
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ChIP-seq data, in all 3 cell lines, which is centered next to
the NF-κB binding peaks, and overlapping with even
stronger peaks for IRF1. Based on our in silico data we did
not find binding sites for IRF3 in this region, which is rather
well conserved in the analyzed species, with the best con-
servation between human and cattle in 7 out of 8 human
variants, and the worst conservation between chimpanzee
and other species (average conservation level 36.57%).
For the REL gene we see peaks in the promoter region
in all analyzed NF-κB ChIP-seq data, with strong signal
near the TSS and in the (500b - 1000b) upstream region.
These regions are overlapped with the strong signal from
IRF1 ChIP-seq data, and a negligible signal from one of
the IRF3 ChIP-seq experiments. Binding sites in the region
close to the TSS are conserved among considered species.
In the promoter region of the IRF1 gene, NF-κB bind-
ing sites are well represented by a strong peak near TSS
site and by a weaker one in the region (500b - 1000b)
upstream of TSS. This is consistent across all cell lines
used for NF-κB binding identification and also consistent
with our computational data. This region is overlapped by
a strong peak signal from IRF1 data and a weak signalFigure 1 Cross-signaling schematic. Signaling pathways activated by viral b
(including their main target, IFNβ). Green arrows: confirmed positive regula
dashed arrows: Co-regulation of unknown type inferred from bioinformatic
on high counts of binding sites in target gene promoters.from one cell line in IRF3 experiments (GM12878). Again
we find conserved NF-κB binding sites in the region close
to TSS site. For one longer human variant there is only a
strong signal from IRF1 binding.
In the IRF2 gene, ChIP-seq data show peaks in 4 out
of 10 NF-κB cell lines; the peaks are centered on the
beginning of the first exon and the TSS site. Lower-
strength signal is present across the whole promoter re-
gion. We found conserved binding sites for NF-κB in
the region covered by the ChIP-seq data peak, with con-
servation across promoter region for human, mouse and
cattle of around 61%, while chimpanzee sequence has
average similarity of 34% with respect to other species.
ChIP-seq data for IRF1 show strong and broad peaks
across the whole promoter range and one weak peak for
IRF3 in only 1 out of 3 cell lines, which is consistent
with our in silico findings, and suggests a stronger re-
sponsiveness to IRF1.
IRF3 gene promoter shows a moderate response to
NF-κB in 4 out of 10 cases, located in the region (0b,
500b) upstream of TSS. Strong peak for IRF1 is located
in the same region as the signal for NF-κB binding, over-
lapping the region of weak signal for IRF3. According toy-products and involving potential targets for IRF3, NF-κB and SP1
tion. Red lines with bullet endings: confirmed negative regulation. Blue
s and evolutionary analysis. Bold lines: Strong association of TF based
Table 3 ChIP-seq data accession numbers


















Accession numbers and cell line origin of data used for cross-reference with
in silico results.
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is present, and binding site for IRF3 is located in the re-
gion of low IRF3 binding signal.
Taking into consideration data for all promoters and
comparing them with our computational predictions, we
conclude that our in silico approach has some merit.
Computationally found binding sites are predominantly
located in regions of experimentally proven bindings and
these regions are also considerably well conserved among
analyzed species.
Conclusions
Our cross-regulation hypothesis, based on in silico
methods is supported by experimental results. Gene
knockdown experiments [13] show that levels of RelA
are increased by IRF3 siRNA silencing, suggesting that
IRF3 may be a negative regulator of RelA expression. In
addition, silencing RelA resulted in upregulation of the
IRF3 expression levels. Similar results were observed for
known NF-κB-dependent genes, such as IL6 or IKBA,
expression levels of which were upregulated in response
to IRF3 silencing. We show these interactions in Figure 1,
which is a proposed conceptual diagram describing inter-
actions between NF-κB and IRF3 pathways at gene pro-
moter level. Presence of interactions between respective
transcription factors is based on in silico TFBS data with
CHIP-seq support as discussed earlier on in the paper,
while direction of this interaction is based on literature
(green lines) or concluded from experimental data (red
lines) [13]. Crosstalk between the two arms of the IIR sys-
tem, at the level of interactions between genes coding for
NF-κB and IRF3 transcription factors and these transcrip-
tion factors, was not presented before. The results are also
consistent with the findings of Wang et al. [27], who show
that overexpression of IRF3 in hepatocytes results in
IKKβ/NF-κB signaling downregulation [27].
Our results show that binding sites for members of
the IRF and NF-κB families do not overlap with each
other but tend to be are alternately arranged. The best
represented member of the IRF family was IRF1. In most
cases only singular IRF3 TFBS were found, usually over-
lapping the better scored IRF1 binding sites. Compared
to the number of the NF-κB binding sites found in the
promoter region of genes encoding the members of NF-
κB and IRF family, the IRF binding sites are relatively
poorly represented. However, location of these few IRF
binding sites appears crucial and interrupts proper bind-
ing of other (activating) transcription factors. Based on
the analysis of TFBS in promoters, the crosstalk between
NF-κB and IRF3 pathway is likely biased toward the ac-
tivity of NF-κB. It was reported that activation of the
NF-κB dependent genes occurs with no delays after NF-
κB enters the nucleus, whereas IRF3 enters nucleus be-
fore NF-κB, but its nuclear translocation profile suggestspresence of additional modifying factors, which delay
IRF3-mediated activation [28]. We conclude that mem-
bers of the IRF family may not have a strong direct impact
on the regulation of genes encoding the members of the
NF-κB family, but rather act indirectly via other transcrip-
tion factors. This cross regulation may be aided by two
other transcription factors, which are distinguished by
high counts of their TFBS in our dataset: AP-1, which tar-
gets the IRF3 gene as well as the REL, RELA, RELB genes,
and potentially SP1, which targets all TF-coding genes in
our dataset, and also targets AP-1. SP1 is known to regu-
late expression of genes involved in apoptosis, cell prolif-
eration, cell differentiation and viral immune response
[29]. To obtain a better insight into the relationship be-
tween analyzed factors we also examined the promoter re-
gions of the genes encoding the SP1 and AP-1 factors.
This analysis shows the presence of crosstalk between
IRF3, AP-1, SP1 and members of NF-κB family. These
findings are consistent with the results from ChIP-seq
data analysis presented in Yang et al. [30], where AP1 and
SP1 are spatially oriented relative to the location of the
NF-κB family motifs, which suggest that they physically
interact. Furthermore observed co-occurrence correlates
with different chromatin context [30].
It is also known that IRF1-mediated activation of IL12
needs cooperation with the SP1 binding elements [31].
Taking these data into consideration we present estab-
lished and hypothetical interdependences in Figure 1.
Based on our in silico analysis we conclude that SP1 is
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mediating the crosstalk between the IRF and NF-κB
pathways. We present extended crosstalk diagram of the
IRF - NF-κB pathways. This work is an extension and a
full report of data supporting IIR model in Bertolusso
et al. [13], but it is focused on transcriptional regulatory
dependencies as well as the role of cofactors SP1 and
AP-1 in the cross-talk between NF-κB and IRF.
Methods
Promoter sequences, defined as 1kB upstream of the
TSS, were identified using UCSC Genome Browser [32]
and were analyzed using NucleoSeq [33] and ConSite
[34] in search for hypothetical transcription factor bind-
ing sites (TFBS) specific for members of IRF and NF-κB
families. We performed analysis of sequences belonging to
human, chimpanzee, cattle and mouse to obtain optimal
evolutionary range across mammals; this choice was
further discussed in Iwanaszko et al. [15]. Cross-species
alignments were performed using ClustalW2 [35]. Cross-
species comparisons were further analyzed using ConSite
[34] and Toucan3.1 [36]. Binding motifs for the NF-κB
family members, as well as AP1, SP-1, IRF1 and IRF2 were
identified using position frequency matrices (PFM) available
in Jaspar [37] which are the special case of position weight
matrices (PWM) used widely for TFBS search. The PFM
for IRF3 was obtained from Lin et al. [38]. Consensus se-
quences for analyzed transcription factors, based on PFM:
GAAASSAAANY (IRF3), GAAWNYGAAANY (IRF7), AGG
AAATTCCG (canonical RELA), RGGRNNHHYYB (gener-
alized NF-κB). ChIP-seq data were retrieved through the
ENCODE project site and the GEO database and used as
cross-reference. Sample accession numbers and cell lines
of origin can be found in Table 3.
Additional files
Additional file 1: Full dataset summary. Table presents the counts
of TFBS corresponding to the IRF family and the NF-κB family of
transcription factors, found in promoters of presented genes in four
species: cattle (bosTau), mouse (mm), chimpanzee (panTro) and human
(hg). Yellow rows correspond to promoters with at least one motif for
IRF3; orange rows correspond to promoters containing motifs of all
members of the IRF family; and rows in bold corresponds to promoter
sequences with SP1 TFBS count higher than average (7.4 motifs/promoter)
for our dataset.
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